Searching a biomedical database from Bulgaria : the ABS database

The University of Sofia, Bulgaria, disseminates local biomedical literature (1994 to present) through a free online database, ABS. We systematically searched ABS to identify citations to controlled trials and find what proportion of these studies are to be found on MEDLINE. We searched using Bulgarian and English phrases; manually selected citations of controlled trials and sought these citations on MEDLINE. Using the two languages we found a total of 628 unique citations, of which 47 of which seem to be relevant controlled trials (precision 7.48%, 13% of ABS citations were found on MEDLINE). The trials in ABS commonly focused on evaluation of care for people with cardiovascular or urological problems

Searching a biomedical database from Bulgaria : the ABS database

The University of Sofia, Bulgaria, disseminates local biomedical literature (1994 to present) through a free online database, ABS. We systematically searched ABS to identify citations to controlled trials and find what proportion of these studies are to be found on MEDLINE. We searched using Bulgarian and English phrases; manually selected citations of controlled trials and sought these citations on MEDLINE. Using the two languages we found a total of 628 unique citations, of which 47 of which seem to be relevant controlled trials (precision 7.48%, 13% of ABS citations were found on MEDLINE). The trials in ABS commonly focused on evaluation of care for people with cardiovascular or urological problems

Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]

To determine the efficacy and safety of risedronate in patients with knee osteoarthritis (OA), the British study of risedronate in structure and symptoms of knee OA (BRISK), a 1-year prospective, double-blind, placebo-controlled study, enrolled patients (40–80 years of age) with mild to moderate OA of the medial compartment of the knee. The primary aims were to detect differences in symptoms and function. Patients were randomized to once-daily risedronate (5 mg or 15 mg) or placebo. Radiographs were taken at baseline and 1 year for assessment of joint-space width using a standardized radiographic method with fluoroscopic positioning of the joint. Pain, function, and stiffness were assessed using the Western Ontario and McMaster Universities (WOMAC) OA index. The patient global assessment and use of walking aids were measured and bone and cartilage markers were assessed. The intention-to-treat population consisted of 284 patients. Those receiving risedronate at 15 mg showed improvement of the WOMAC index, particularly of physical function, significant improvement of the patient global assessment (P < 0.001), and decreased use of walking aids relative to patients receiving the placebo (P = 0.009). A trend towards attenuation of joint-space narrowing was observed in the group receiving 15 mg risedronate. Eight percent (n = 7) of patients receiving placebo and 4% (n = 4) of patients receiving 5 mg risedronate exhibited detectable progression of disease (joint-space width ≥ 25% or ≥ 0.75 mm) versus 1% (n = 1) of patients receiving 15 mg risedronate (P = 0.067). Risedronate (15 mg) significantly reduced markers of cartilage degradation and bone resorption. Both doses of risedronate were well tolerated. In this study, clear trends towards improvement were observed in both joint structure and symptoms in patients with primary knee OA treated with risedronate

Spawning grounds of Atlantic cod (Gadus morhua) in the North Sea

The protection of spawning fish from anthropogenic impacts requires information on the location, timing, and interannual persistence of spawning aggregations. In this study, generalized additive models were used to predict the spawning habitat of North Sea cod, based on the abundance of spawning fish within three population subareas and nine environmental layers. The length of spawning cod differed among population subareas, consistent with published evidence of maturation differences. In the northeast North Sea (Viking), the peak in the spawning season was estimated to occur after the survey which made the prediction of spawning grounds for this area less certain. Cod were found to prefer areas with temperatures around 5–7°C for spawning and there was a general preference for high salinity waters. Persistence of cod spawning grounds over the study period was related to interannual stability in temperature, with high variability in the use of Southern Bight spawning grounds. As such, cod appear to minimize interannual variability in the initial environmental conditions affecting offspring survival by selecting suitable cold spawning grounds. Seabed conditions also affected spawning distribution with cod selecting coarse sand and avoiding areas of very high tidal flow. The model prediction was compared with the distribution of cod aggregations during the spawning season reported by fishing boats. Seventy per cent of the aggregations was located in areas classified as occasional or recurrent spawning grounds. The predicted distribution confirmed the widespread occurrence of spawning in the North Sea and showed good agreement with recent and past studies of cod egg distribution, suggesting that nearly all major historical areas of spawning still appear in use today. However, the study also found that the recent recovery of spawning-stock biomass was not uniform across the stock, being centred in the northwest subarea